The latest data point in Q2'26 shows total operating expenses of 4.05B, with R&D Expenses at 2.995B and SG&A Expenses at 1.055B. From Q3'23 to Q2'26, operating expenses exhibited significant growth following the Q1'24 acquisition-related spike, with R&D Expenses rising from 1.358B to 2.995B as the dominant component, while SG&A Expenses increased from 388M to 1.055B and stabilized around 1B after the initial surge, reflecting sustained higher cost structure post-acquisition.